 Opioid-Related Disorders
"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from abuse or mis-use of opioids.
| Descriptor ID |
D009293
|
| MeSH Number(s) |
C25.775.675 F03.900.675
|
| Concept/Terms |
Opioid-Related Disorders- Opioid-Related Disorders
- Disorder, Opioid-Related
- Opioid Abuse
- Abuse, Opioid
- Abuses, Opioid
- Opioid Abuses
- Opiate Abuse
- Abuse, Opiate
- Abuses, Opiate
- Opiate Abuses
Opiate Dependence- Opiate Dependence
- Dependence, Opiate
- Opiate Addiction
- Addiction, Opiate
|
Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".
This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 1 | 2 | | 2006 | 2 | 0 | 2 | | 2007 | 1 | 2 | 3 | | 2008 | 0 | 1 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 4 | 0 | 4 | | 2014 | 9 | 0 | 9 | | 2015 | 6 | 0 | 6 | | 2016 | 7 | 2 | 9 | | 2017 | 15 | 2 | 17 | | 2018 | 18 | 8 | 26 | | 2019 | 27 | 7 | 34 | | 2020 | 35 | 2 | 37 | | 2021 | 28 | 2 | 30 | | 2022 | 41 | 0 | 41 | | 2023 | 41 | 0 | 41 | | 2024 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999.
-
Christine PJ, Goldman AL, Morgan JR, Yan S, Chatterjee A, Bettano AL, Binswanger IA, LaRochelle MR. Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis. JAMA Health Forum. 2024 Jul 05; 5(7):e242014.
-
Kim TW, Bertholet N, Magane KM, Lloyd-Travaglini C, Winter MR, Samet JH, Erlandson KM, Stein MD, Bryant KJ, Saitz R, Heeren TC. Alcohol Consumption and Illicit Drug Use: Associations With Fall, Fracture, and Acute Health Care Utilization Among People With HIV Infection. J Acquir Immune Defic Syndr. 2024 04 01; 95(4):391-398.
-
Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 07; 119(7):1313-1321.
-
Shahlapour M, Singh S, Christine PJ, Laks J, Evans J, Farrell NM, Khan GK, Taylor JL, Rozansky H. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic. J Addict Med. 2024 May-Jun 01; 18(3):345-347.
-
Gibbons JB, Li W, Stuart EA, Saloner B. Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder. Health Serv Res. 2024 10; 59(5):e14271.
-
Callister C, Porter S, Vatterott P, Keniston A, McBeth L, Mann S, Calcaterra SL, Limes J. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder. Subst Use Addctn J. 2024 Jul; 45(3):356-366.
-
Gibbons JB, McCullough JS, Zivin K, Brown ZY, Norton EC. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare. J Subst Use Addict Treat. 2024 02; 157:209271.
-
Duffy EP, Bachtell RK, Ehringer MA. Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome. Neurosci Biobehav Rev. 2024 Jan; 156:105487.
-
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA? ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|